All articles tagged with #gabapentin
Gabapentin, a widely prescribed medication originally for seizures and nerve pain, has seen a significant rise in use, often prescribed off-label, raising concerns about its safety profile, including side effects, serious allergic reactions, breathing issues, and potential for misuse and mental health impacts. Patients and doctors should be aware of these hidden dangers and monitor for adverse symptoms.
A recent study suggests that gabapentin, a drug commonly prescribed for chronic back pain, may be associated with an increased risk of dementia, especially in adults under 65, raising concerns about its long-term effects on brain health.
Recent studies suggest that long-term or frequent use of gabapentin may be associated with an increased risk of dementia and mild cognitive impairment, especially in users aged 35-64. While not proving causation, these findings prompt a reevaluation of its long-term use, emphasizing the importance of consulting healthcare providers, exploring alternatives, and adopting lifestyle measures to protect brain health.
A study links the use of gabapentin, a drug for nerve pain and epilepsy, with an increased risk of dementia and mild cognitive impairment, especially among younger adults, prompting physicians to monitor cognitive health in patients prescribed the medication.
A recent study suggests that taking six or more prescriptions of gabapentin for lower back pain may significantly increase the risk of developing dementia and mild cognitive impairment, especially in adults aged 35 to 49, highlighting the need for cautious prescribing and monitoring.
Recent research suggests a significant association between the use of gabapentin, a common medication for chronic pain, and an increased risk of developing dementia and cognitive impairment, prompting calls for more cautious prescribing and monitoring by healthcare providers.
A study by Case Western University found that gabapentin, a drug used for nerve pain and seizures, may significantly increase the risk of dementia and cognitive impairment, especially with frequent use, raising concerns about its long-term safety.
A study suggests that gabapentin, a common medication for back pain, may be associated with an increased risk of dementia and mild cognitive impairment, especially with frequent use and in certain age groups, highlighting the need for careful monitoring of patients on this drug.
A recent study suggests that regular use of gabapentin, a drug for nerve pain and seizures, may be associated with an increased risk of dementia and mild cognitive impairment, especially in younger adults aged 18-64, highlighting the need for further research and monitoring.
A large U.S. study found that adults prescribed gabapentin six or more times for chronic low back pain have significantly higher risks of developing dementia and mild cognitive impairment within 10 years, especially among those aged 35–64, suggesting a potential link between the medication and cognitive decline that warrants close monitoring.
A large study suggests that taking six or more prescriptions of gabapentin for chronic pain may significantly increase the risk of developing dementia and mild cognitive impairment, especially in adults aged 18-64, highlighting the need for careful monitoring of patients on this medication.
Type 2 diabetes can often be prevented and treated with a lifestyle that includes regular moderate exercise and a mostly plant-based diet, with medication like metformin if necessary; gabapentin, a medication for chronic pain, can cause withdrawal symptoms such as tremors if stopped suddenly, and should be tapered slowly under medical supervision.
Dr. Roach suggests that the best medicine for Type 2 diabetes is actually none, emphasizing the importance of lifestyle changes such as regular exercise and a plant-based diet. For those requiring medication, metformin is often the initial choice, with additional medications tailored to individual needs. In another query, Dr. Roach advises that sudden cessation of gabapentin can lead to withdrawal symptoms, and recommends restarting the medication at the previous dose and tapering slowly to mitigate these effects.
Scientists at UC San Francisco have discovered that neural activity in glioblastoma brain tumors can restructure connections in surrounding brain tissue, leading to cognitive decline. They have also found that the drug gabapentin can block this activity in mice. This research opens up new possibilities for treating glioblastoma and other neural cancers by targeting communication networks between cells. The study suggests that the brain's networks can be exploited by tumors and that gabapentin, typically used for seizure prevention, could potentially extend the lives of patients and reduce cognitive decline.
Pregabalin and gabapentin are similar drugs belonging to the anticonvulsant class, but they have different FDA-approved indications and dosages. While both are used to treat postherpetic neuralgia and partial seizures, pregabalin has additional approvals for fibromyalgia and nerve pain. Healthcare providers often prescribe these medications off-label for conditions like anxiety disorders. Pregabalin is more potent than gabapentin on a per-milligram basis and comes in lower strengths. The dosages for both drugs depend on the condition being treated, and they have similar side effects. Pregabalin is a controlled substance, while gabapentin is not. It's important to consult a healthcare provider for proper dosing and to discuss any potential interactions or side effects.